Physician profile
Wesley S Bennett
NPI 1730166307
$6,388.69
in general payments reported to CMS, 2019-2025
33 companies · $441 in 2025
The $441 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $855 · 2020: $808 · 2021: $1,130 · 2022: $1,975 · 2023: $842 · 2024: $336 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,891.03 | 2021-2025 | Venaseal, Symplicity G3, Micra |
| Abiomed | $1,245.39 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $1,135.31 | 2019-2025 | |
| Pfizer INC. | $225.17 | 2019-2025 | |
| Celonova Biosciences, INC. | $217.14 | 2019 | |
| Philips North America LLC | $206.62 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $184.03 | 2021-2025 | Verquvo |
| Amgen INC. | $138.85 | 2021-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $132.07 | 2020-2025 | Wainua, Farxiga |
| Boston Scientific Corporation | $124.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $115.27 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $106.29 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.85 | 2023 | Jardiance |
| Medtronic Vascular, INC. | $83.53 | 2019 | |
| Abbott Laboratories | $78.72 | 2019-2023 | Cardiomems, Diamondback Coronary |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $73.56 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $35.97 | 2023 | |
| W. L. Gore & Associates, INC. | $30.88 | 2024 | Gore Tag Conformable Thoracic Stent Graft |
| Silk Road Medical, INC. | $27.90 | 2022 | |
| Esperion Therapeutics, INC. | $27.79 | 2025 | Nexletol |
| Bard Peripheral Vascular, INC. | $21.82 | 2023 | Rotarexs 6 F X 135 Cm |
| Astellas Pharma US INC | $20.98 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.87 | 2025 | Lifevest |
| Cardiva Medical, INC. | $20.85 | 2024 | Optowire |
| Bayer Healthcare Pharmaceuticals INC. | $20.11 | 2023 | |
| Terumo Medical Corporation | $19.73 | 2022 | |
| Cvrx, INC. | $18.52 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $15.20 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Itamar Medical INC | $14.89 | 2023 | Watchpatone |
| Lexicon Pharmaceuticals, INC. | $13.26 | 2024 | |
| Novo Nordisk INC | $11.73 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.